Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis

This study has been completed.
Sponsor:
Collaborators:
Medecins Sans Frontieres
PNLTHA-DRC;
PNLTHA-RoC
Epicentre
Swiss Tropical & Public Health Institute
World Health Organization
Information provided by:
Drugs for Neglected Diseases
ClinicalTrials.gov Identifier:
NCT00146627
First received: September 6, 2005
Last updated: September 18, 2009
Last verified: September 2009